157 related articles for article (PubMed ID: 29028769)
1. Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia-Reperfusion Injury.
Wang X; Li S; Chen M; Liu J; Dong R; Wang H; Zhu S
Shock; 2018 Sep; 50(3):316-323. PubMed ID: 29028769
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.
Ceulemans LJ; Verbeke L; Decuypere JP; Farré R; De Hertogh G; Lenaerts K; Jochmans I; Monbaliu D; Nevens F; Tack J; Laleman W; Pirenne J
PLoS One; 2017; 12(1):e0169331. PubMed ID: 28060943
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis.
Xu Y; Li D; Wu J; Zhang M; Shao X; Xu L; Tang L; Zhu M; Ni Z; Zhang M; Mou S
Cell Prolif; 2021 Apr; 54(4):e13005. PubMed ID: 33594777
[TBL] [Abstract][Full Text] [Related]
4. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway.
He X; Zheng Y; Liu S; Shi S; Liu Y; He Y; Zhang C; Zhou X
J Cell Physiol; 2018 Mar; 233(3):2476-2488. PubMed ID: 28771774
[TBL] [Abstract][Full Text] [Related]
5. A naturally occurring FXR agonist, alisol B 23-acetate, protects against renal ischemia-reperfusion injury.
Luan ZL; Ming WH; Sun XW; Zhang C; Zhou Y; Zheng F; Yang YL; Guan YF; Zhang XY
Am J Physiol Renal Physiol; 2021 Nov; 321(5):F617-F628. PubMed ID: 34569253
[TBL] [Abstract][Full Text] [Related]
6. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
7. Activation of NF-κB pathway in oral buccal mucosa during small intestinal ischemia-reperfusion injury.
Kim SI; Kim YB; Koh KM; Youn YK; Suh GJ; Cho ES; Leem DH; Baek JA; Shin HK; Ko SO
J Surg Res; 2013 Jan; 179(1):99-105. PubMed ID: 22985774
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
[TBL] [Abstract][Full Text] [Related]
9. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine.
Gadaleta RM; Oldenburg B; Willemsen EC; Spit M; Murzilli S; Salvatore L; Klomp LW; Siersema PD; van Erpecum KJ; van Mil SW
Biochim Biophys Acta; 2011 Aug; 1812(8):851-8. PubMed ID: 21540105
[TBL] [Abstract][Full Text] [Related]
10. The bile acid receptor FXR is a modulator of intestinal innate immunity.
Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice.
Shan HM; Zang M; Zhang Q; Shi RB; Shi XJ; Mamtilahun M; Liu C; Luo LL; Tian X; Zhang Z; Yang GY; Tang Y; Pu J; Wang Y
J Neuroinflammation; 2020 May; 17(1):164. PubMed ID: 32450881
[TBL] [Abstract][Full Text] [Related]
12. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
[TBL] [Abstract][Full Text] [Related]
13. TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion.
Ben DF; Yu XY; Ji GY; Zheng DY; Lv KY; Ma B; Xia ZF
J Surg Res; 2012 May; 174(2):326-33. PubMed ID: 21392794
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA files in the prevention of intestinal ischemia/reperfusion injury by hydrogen rich saline.
Yao W; Lin X; Han X; Zeng L; Guo A; Guan Y; Hei Z; Liu J; Huang P
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31789347
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-682-mediated downregulation of PTEN in intestinal epithelial cells ameliorates intestinal ischemia-reperfusion injury.
Liu Z; Jiang J; Yang Q; Xiong Y; Zou D; Yang C; Xu J; Zhan H
Cell Death Dis; 2016 Apr; 7(4):e2210. PubMed ID: 27124584
[TBL] [Abstract][Full Text] [Related]
16. Obeticholic acid attenuates the intestinal barrier disruption in a rat model of short bowel syndrome.
Hou L; Wang H; Yan M; Cai Y; Zheng R; Ma Y; Tang W; Jiang W
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167221. PubMed ID: 38718845
[TBL] [Abstract][Full Text] [Related]
17. Hypertonic saline activates CD4+ and CD8+ T-lymphocytes in the small intestine to alleviate intestinal ischemia-reperfusion injury.
Yang DJ; Zhu ZX; Fu HB; Yan RL; Chen J; Cheng YJ; Cai QP; Wang Q
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3069-75. PubMed ID: 25392107
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol ameliorates subacute intestinal ischemia-reperfusion injury.
Dong W; Li F; Pan Z; Liu S; Yu H; Wang X; Bi S; Zhang W
J Surg Res; 2013 Nov; 185(1):182-9. PubMed ID: 23735732
[TBL] [Abstract][Full Text] [Related]
19. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
[TBL] [Abstract][Full Text] [Related]
20. Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice.
Fiorucci S; Mencarelli A; Cipriani S; Renga B; Palladino G; Santucci L; Distrutti E
Br J Pharmacol; 2011 Dec; 164(8):1929-38. PubMed ID: 21564085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
